Brief: NW Bio reaches agreement with convertible note holders
10/03/2017 13:15
March 10 (Reuters) - Northwest Biotherapeutics Inc NWBO.PK
* NW Bio reaches agreement with convertible note holders
* Northwest Biotherapeutics Inc - Has signed a note
repurchase agreement with a group of bondholders affiliated with
Whitebox Advisors
* Northwest Biotherapeutics - Co, Whitebox negotiated a time
payment approach tailored to co's development schedule with
increasing periodic payments over next 4 months
* Northwest Biotherapeutics Inc - As part of consideration
for the adjustments, Whitebox also will be receiving NW Bio
common stock
Source text for Eikon: ID:nPn8p7gW2a
Further company coverage: NWBO.PK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Northwest Biotherapeutics
See all newsBrief: Northwest Biotherapeutics And The UK National Health Service Blood And Transplant Announce Collaboration To Support Dcvax®-L Production
Brief: Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application
Brief: Northwest Biotherapeutics Provides Update On Near Term Plans For Submission Of Marketing Authorization Application
Brief: Northwest Biotherapeutics And Advent Bioservices Announce Receipt Of License For Commercial Manufacturing At Sawston, U.K. Facility
Brief: Northwest Biotherapeutics Announces That It Has No Banking Relationship With SVB